Technical Analysis for GSS - Genetic Signatures Ltd  

Grade Last Price % Change Price Change
A 0.717 2.43% 0.017
GSS closed up 2.43 percent on Thursday, November 21, 2024, on 31 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Nov 28
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish 2.43%
Overbought Stochastic Strength 2.43%
Overbought Stochastic Strength -0.42%
Gapped Down Weakness -0.42%
Narrow Range Bar Range Contraction 0.99%
Gapped Up Strength 0.99%
Overbought Stochastic Strength 0.99%
Stochastic Sell Signal Bearish 3.91%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 11 hours ago
Up 2% about 11 hours ago
Up 1% about 11 hours ago
Fell Below 10 DMA about 12 hours ago
Down 2% 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genetic Signatures Ltd   Description

Genetic Signatures Limited is a molecular diagnostics company. The Company is engaged in the research and commercialization of identifying individual genetic signature to identify diseases and disabilities, and the sale of associated products into diagnostic and research market place. It is focused on the development and commercialization of its platform technology, 3Base. The Company has a suite of polymerase chain reaction (PCR)-based products for the detection of infectious diseases under the EasyScreen brand. Its product portfolio includes EasyScreen detection kits and MethylEasy research kits. The Company's 3base technology forms the basis of its EasyScreen Pathogen Detection Kits. Its EasyScreen products provide hospital and pathology laboratories with the molecular tools to screen for an array of infectious pathogens. Its MethylEasy research kits include Methyl Easy Xceed, which is a bisulfite modification research kit for the detection of methylation patterns in genes.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Chemistry Biotechnology Disease Hospital Diseases Biology Nature Platform Technology Pathology Infectious Diseases Easy Molecular Diagnostics Infectious Disease Laboratory Techniques Molecular Biology Polymerase Chain Reaction

Is GSS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.85
52 Week Low 0.38
Average Volume 60,797
200-Day Moving Average 0.675
50-Day Moving Average 0.663
20-Day Moving Average 0.679
10-Day Moving Average 0.703
Average True Range 0.023
RSI (14) 57.98
ADX 23.18
+DI 31.248
-DI 18.554
Chandelier Exit (Long, 3 ATRs) 0.650
Chandelier Exit (Short, 3 ATRs) 0.675
Upper Bollinger Bands 0.752
Lower Bollinger Band 0.606
Percent B (%b) 0.76
BandWidth 21.564
MACD Line 0.017
MACD Signal Line 0.013
MACD Histogram 0.0036
Fundamentals Value
Market Cap 102.44 Million
Num Shares 143 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -21.09
Price-to-Sales 19.72
Price-to-Book 5.44
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.747
Resistance 3 (R3) 0.745 0.732 0.742
Resistance 2 (R2) 0.732 0.725 0.734 0.740
Resistance 1 (R1) 0.725 0.720 0.729 0.727 0.739
Pivot Point 0.712 0.712 0.714 0.714 0.712
Support 1 (S1) 0.705 0.705 0.709 0.707 0.695
Support 2 (S2) 0.692 0.700 0.694 0.694
Support 3 (S3) 0.685 0.692 0.692
Support 4 (S4) 0.687